These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33398723)

  • 1. Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts.
    Shi-Wen X; Racanelli M; Ali A; Simon A; Quesnel K; Stratton RJ; Leask A
    J Cell Commun Signal; 2021 Mar; 15(1):71-80. PubMed ID: 33398723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblasts.
    Murphy-Marshman H; Quensel K; Shi-Wen X; Barnfield R; Kelly J; Peidl A; Stratton RJ; Leask A
    PLoS One; 2017; 12(10):e0186740. PubMed ID: 29049376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
    Peidl A; Perbal B; Leask A
    PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts.
    Shi-wen X; Thompson K; Khan K; Liu S; Murphy-Marshman H; Baron M; Denton CP; Leask A; Abraham DJ
    Rheumatology (Oxford); 2012 Dec; 51(12):2146-54. PubMed ID: 22977060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.
    Leask A
    Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts.
    Chen Y; Shi-wen X; Eastwood M; Black CM; Denton CP; Leask A; Abraham DJ
    Arthritis Rheum; 2006 Apr; 54(4):1309-16. PubMed ID: 16575856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts.
    Chen Y; Leask A; Abraham DJ; Pala D; Shiwen X; Khan K; Liu S; Carter DE; Wilcox-Adelman S; Goetinck P; Denton CP; Black CM; Pitsillides AA; Sarraf CE; Eastwood M
    Arthritis Rheum; 2008 Feb; 58(2):577-85. PubMed ID: 18240216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.
    Shi-Wen X; Renzoni EA; Kennedy L; Howat S; Chen Y; Pearson JD; Bou-Gharios G; Dashwood MR; du Bois RM; Black CM; Denton CP; Abraham DJ; Leask A
    Matrix Biol; 2007 Oct; 26(8):625-32. PubMed ID: 17681742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosis.
    Quesnel K; Shi-Wen X; Hutchenreuther J; Xiao Y; Liu S; Peidl A; Naskar D; Siqueira WL; O'Gorman DB; Hinz B; Stratton RJ; Leask A
    Matrix Biol Plus; 2019 Aug; 3():100009. PubMed ID: 33543008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.
    Leask A; Sa S; Holmes A; Shiwen X; Black CM; Abraham DJ
    Mol Pathol; 2001 Jun; 54(3):180-3. PubMed ID: 11376132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
    Shi-wen X; Kennedy L; Renzoni EA; Bou-Gharios G; du Bois RM; Black CM; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2007 Dec; 56(12):4189-94. PubMed ID: 18050250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.
    Rajkumar VS; Howell K; Csiszar K; Denton CP; Black CM; Abraham DJ
    Arthritis Res Ther; 2005; 7(5):R1113-23. PubMed ID: 16207328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The yes-associated protein-1 (YAP1) inhibitor celastrol suppresses the ability of transforming growth factor β to activate human gingival fibroblasts.
    Naik A; Chitturi P; Nguyen J; Leask A
    Arch Oral Biol; 2024 Apr; 160():105910. PubMed ID: 38364717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
    Shi-wen X; Pennington D; Holmes A; Leask A; Bradham D; Beauchamp JR; Fonseca C; du Bois RM; Martin GR; Black CM; Abraham DJ
    Exp Cell Res; 2000 Aug; 259(1):213-24. PubMed ID: 10942593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
    Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A
    J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.
    Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
    Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
    Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
    Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.